We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

6,400 to go - and counting

3 Nov 2005 By Robert Cyran

The drug group has won the second Vioxx liability challenge. Good for it, as all the facts were stacked in its favour. But shareholders shouldn’t get overexcited just yet. Merck has close to 6,500 cases to go and the number is mounting.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)